Federal Register / Vol. 87, No. 84 / Monday, May 2, 2022 / Notices 25639 

GENERAL SERVICES 

ADMINISTRATION 

[Notice–MA–2022–02; Docket No. 2022– 

0002, Sequence No. 2] 

Government Bill of Lading (GBL) and 

Government Transportation Request 

(GTR) Forms 

AGENCY: Office of Government-wide 

Policy (OGP), U.S. General Services 

Administration (GSA). 

ACTION: Notice of GSA Bulletin Federal 

Management Regulation (FMR) D–5, 

Transportation Payment and Audit, 

Updated Guidance Regarding 

Government Bill of Lading (GBL) and 

Government Transportation Request 

(GTR) Forms. 

SUMMARY: GSA is issuing GSA Bulletin 

FMR D–5 which informs agencies that 

Government Bill of Lading (GBL) and 

Government Transportation Request 

(GTR) forms are available online. 

Agencies no longer need to contact GSA 

for paper copies of the forms or to 

receive assigned serialized numbers for 

these forms. 

DATES: Applicability date: May 2, 2022. 

This notice remains in effect until 

publication of FMR Case 2018–102–5. 

FOR FURTHER INFORMATION CONTACT: For 

clarification of content, please contact 

Mr. Ron Siegel, Program Analyst, Office 

of Government-wide Policy, Office of 

Asset and Transportation Management, 

at 202–702–0840, or by email at GSAOGP-transportationpolicy@gsa.gov. 

Please cite Notice of GSA Bulletin FMR 

D–5 in the subject line. 

SUPPLEMENTARY INFORMATION: In the 

past, GSA printed multi-part GBL and 

GTR forms for distribution to Federal 

agencies. GSA has not printed these 

forms in many years. The FMR instructs 

agencies to contact GSA for copies of 

GBL and GTR forms in preprinted or 

blank formats. Agencies that need 

copies of these forms can now find them 

available online in the GSA Forms 

Library (https://www.gsa.gov/reference/ 

forms). The FMR also instructs agencies 

that do not use pre-numbered GBL or 

GTR forms to contact GSA for assigned 

sets of serialized numbers. However, 

since agencies are already required to 

establish administrative procedures 

such as a unique numbering system 

tracking numbers, GSA no longer 

provides serialized numbers to agencies. 

Upon publication of FMR Case 2018– 

1102–5 in the Federal Register, the 

sections that discuss GBL and GTR 

forms and their numbers, along with 

other sections, will be updated. 

Krystal J. Brumfield, 

Associate Administrator, Office of 

Government-wide Policy. 

[FR Doc. 2022–09365 Filed 4–29–22; 8:45 am] 

BILLING CODE 6820–14–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Agency for Healthcare Research and 

Quality 

Agency Information Collection 

Activities: Proposed Collection; 

Comment Request 

AGENCY: Agency for Healthcare Research 

and Quality, HHS. 

ACTION: Notice of request for 

information regarding potential 

Consumer Assessment of Healthcare 

Providers and System (CAHPS®) survey 

for Inpatient Mental Healthcare settings. 

SUMMARY: AHRQ invites public 

comment on its Request for Information 

(RFI) about a potential Consumer 

Assessment of Healthcare Providers and 

Systems (CAHPS®) survey to assess 

patient care experiences in inpatient 

mental healthcare settings. Specifically, 

this RFI seeks comment regarding 

methodologically sound survey and data 

collection approaches of care 

experiences of those receiving inpatient 

mental healthcare. In addition, this RFI 

seeks comments about any unique 

considerations or concerns associated 

with collection of such patient care 

experience information. There currently 

is no CAHPS instrument designed to 

measure care from the patient 

perspective in this setting. This request 

for information will help inform the 

development of a scientifically sound 

survey to measure the experience of 

patients receiving inpatient mental 

healthcare. 

DATES: Comments on this notice must be 

received by July 1, 2022. 

ADDRESSES: Interested parties may 

submit comments electronically to 

CAHPS1@westat.com with the subject 

line Inpatient Mental Health Experience 

of Care RFI. Non-electronic responses 

will also be accepted. Please mail to 

CAHPS RFI; Westat; 1600 Research 

Blvd.; RB 1186S; Rockville, MD 20850. 

FOR FURTHER INFORMATION CONTACT: 

Questions may be addressed to Caren 

Ginsberg, Director, CAHPS and SOPS 

Programs, Center for Quality 

Improvement and Patient Safety, 

caren.ginsberg@ahrq.hhs.gov, or (301) 

427–1894. 

SUPPLEMENTARY INFORMATION: AHRQ is 

seeking public comment about data 

collection approaches and strategies to 

optimize the meaningfulness of patient 

experience information from patients 

receiving inpatient mental healthcare to 

inform the development of a CAHPS 

survey. AHRQ’s CAHPS Program 

advances scientific understanding of 

patient healthcare experiences using 

surveys developed for different 

healthcare settings. The CAHPS surveys 

cover topics that are important to 

patients and that they are best able to 

assess, such as communication with 

providers and access to health care 

services. This information can address 

the information needs of survey 

sponsors, users, patients, consumers, 

and other stakeholders. 

Specific questions of interest to 

AHRQ include, but are not limited to, 

the following: 

1. What are the highest priority 

aspects of patient experiences with 

inpatient mental healthcare that should 

be included in measures and surveys? 

a. Why are these aspect(s) of patient 

experience a high priority for inclusion 

within assessment tools? 

b. What other topic area(s) should 

new measures and/or surveys assessing 

patient experiences with inpatient 

mental healthcare address? 

2. What are the benefits of collecting 

information about the experience of 

patients in inpatient mental health 

settings from (a) patients and/or (b) 

patients’ family members/caregivers? 

a. What are the benefits and/or 

limitations of asking patients to respond 

to a patient experience of care survey? 

b. What are the benefits and/or 

limitations of asking family members/ 

caregivers to respond to surveys about 

patient experience on behalf of patients? 

c. What are the benefits and/or 

limitations of asking family members/ 

caregivers to respond to surveys about 

their personal experience with their 

family member? 

3. What, if any, challenges are there 

to collecting information about the 

experience of patients in inpatient 

mental health settings? 

4. What would facilitate the collection 

of information about the experience of 

patients in inpatient mental health 

settings? 

5. For which respondent group(s) 

should measures and/or surveys be 

developed? For example, should 

measure and/or surveys be developed 

for adults, children, or both? 

a. In which language(s) should 

measures and/or surveys about the 

experience of patients in inpatient 

mental health settings be administered? 


jspears on DSK121TN23PROD with NOTICES1
25640 Federal Register / Vol. 87, No. 84 / Monday, May 2, 2022 / Notices 

b. Which patient conditions (e.g., 

personality disorders; depression; 

schizophrenia; substance use disorder; 

co-occurring disorders (e.g., mental 

health and substance use disorders; 

etc.)) should these measures and/or 

surveys focus on in documenting the 

experience of patients in inpatient 

mental health settings? 

c. In what kinds of inpatient facilities, 

including public and private psychiatric 

hospitals, nonfederal general hospitals 

with separate psychiatric units, the U.S. 

Department of Veterans Affairs medical 

centers, and day treatment or partial 

hospitalization mental health facilities 

should these measures and/or surveys 

be administered? 

6. What measures and surveys that 

assess the experience of patients in 

inpatient mental health settings are 

currently being used? 

a. Which respondent group(s) (e.g., 

patients in inpatient settings; family 

members; providers; etc.) are asked to 

complete these measures and surveys? 

b. In which language(s) are these 

current measures and surveys 

administered? 

c. Which patient conditions (e.g., 

personality disorders; depression; 

schizophrenia; substance use disorder; 

co-occurring disorders; etc.) are the 

focus of current measures and surveys 

about the experience of patients in 

inpatient mental health settings? 

d. What kinds of inpatient facilities 

including public and private psychiatric 

hospitals, nonfederal general hospitals 

with separate psychiatric units, the U.S. 

Department of Veterans Affairs medical 

centers, and day treatment or partial 

hospitalization mental health facilities 

are using these current measures or 

surveys? 

e. What patient experiences relative to 

the use of restraint and seclusion in 

inpatient facilities are captured using 

these current measures or surveys? 

f. Do any current measures or surveys 

collect information about the degree of 

adherence to patient rights in inpatient 

facilities? 

g. How are these currently used 

measures and surveys administered 

(e.g., paper-and-pencil; web-based; etc.) 

to these respondents group(s)? 

h. How are the results/findings of 

these measures and surveys of patient 

experience in inpatient mental 

healthcare used and in which setting(s)? 

i. What is working well/what are the 

strengths of these measures and surveys 

currently in use? 

j. What content areas are missing from 

these measures and surveys currently in 

use? 

k. What content areas are low priority 

or not useful in these currently used 

measures and surveys, and why? 

l. What, if any, challenges are there in 

administering these measures and 

surveys in current use? 

m. How are the results/findings of 

these current measures and surveys 

used to evaluate and/or improve care 

quality in inpatient mental healthcare 

settings? 

Respondents are welcome to address 

as many or as few of these questions as 

they choose and/or to address 

additional areas of interest not listed. 

This RFI is for planning purposes 

only and should not be construed as a 

policy, solicitation for applications, or 

as an obligation on the part of the 

Government to provide support for any 

ideas in response to it. AHRQ will use 

the information submitted in response 

to this RFI at its discretion, and will not 

provide comments to any respondent’s 

submission. However, responses to this 

RFI may be reflected in future 

solicitation(s) or policies. Respondents 

are advised that the Government is 

under no obligation to acknowledge 

receipt of the information received or 

provide feedback to respondents with 

respect to any information submitted. 

No proprietary, classified, confidential 

or sensitive information should be 

included in your response. The 

Government reserves the right to use 

any non-proprietary technical 

information in any resultant 

solicitation(s). The contents of all 

submissions will be made available to 

the public upon request. Submitted 

materials must be publicly available or 

able to be made public. 

Dated: April 26, 2022. 

Marquita Cullom, 

Associate Director. 

[FR Doc. 2022–09320 Filed 4–29–22; 8:45 am] 

BILLING CODE 4160–90–P 

DEPARTMENT OF HEALTH AND 

HUMAN SERVICES 

Centers for Disease Control and 

Prevention 

Solicitation of Nominations for 

Appointment as Members of the 

Community Preventive Services Task 

Force (CPSTF) 

AGENCY: Centers for Disease Control and 

Prevention (CDC), Department of Health 

and Human Services (HHS). 

ACTION: Notice. 

SUMMARY: The Centers for Disease 

Control and Prevention (CDC), within 

the Department of Health and Human 

Services (HHS), is soliciting 

nominations for appointment of 

individuals qualified to serve as new 

members of the Community Preventive 

Services Task Force (CPSTF). New 

CPSTF members will serve a five-year 

term starting in either 2023 or 2024. For 

efficiency and to reduce the burden on 

the public, CDC is soliciting 

nominations to fill vacancies on the 

CPSTF anticipated for both calendar 

years 2023 and 2024. 

DATES: Nomination packages must be 

received on or before 5:00 p.m. EDT, on 

June 24, 2022. Late nomination 

packages will not be considered. 

ADDRESSES: Nomination packages 

should be submitted by either of the 

methods listed below: 

• Electronically by emailing to 

CPSTF@cdc.gov; or 

• U.S. mail to The Community Guide 

Office, Office of the Associate Director 

for Policy and Strategy, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE, MS H21–10, Atlanta, 

GA 30329. Attn: CPTSTF Nominations. 

FOR FURTHER INFORMATION CONTACT: Julie 

Racine-Parshall, Community Guide 

Office, Office of the Associate Director 

for Policy and Strategy, Centers for 

Disease Control and Prevention, 1600 

Clifton Road NE, MS H21–10, Atlanta, 

Georgia, 30329. Telephone (770) 488– 

0732; Email: CPSTF@cdc.gov. 

SUPPLEMENTARY INFORMATION: The 

submission process, qualification 

requirements, selection process, and the 

time commitment of CPSTF members 

are described below. 

Submission of Nomination Packages 

Nomination packages should include: 

(1) The nominee’s current curriculum 

vitae; 

(2) A brief biographic sketch (less 

than 200 words) of the nominee; 

(3) The nominee’s contact 

information, including mailing address, 

email address, and telephone number; 

and 

(4) A brief explanation of how the 

nominee meets the qualification 

requirements and would contribute to 

the CPSTF. The information provided 

should also attest to the nominee’s 

willingness to serve as a member of the 

CPSTF and identify which year the 

nominee would be available to start (i.e., 

calendar year 2023, 2024, or either 

year). 

After an initial review, CDC will ask 

persons under serious consideration for 

CPSTF membership to provide detailed 

information that will permit evaluation 

of possible significant conflicts of 

interest. 

To obtain diverse perspectives, CDC 

encourages nominations of persons of 


jspears on DSK121TN23PROD with NOTICES1